Ignite Creation Date:
2025-12-24 @ 5:06 PM
Ignite Modification Date:
2025-12-28 @ 4:36 PM
Study NCT ID:
NCT06240650
Status:
COMPLETED
Last Update Posted:
2024-08-09
First Post:
2023-12-28
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tolerability of a Modified Health-Dx
Sponsor:
Celero Systems, Inc.
Organization:
Study Overview
Official Title:
Randomized Controlled Study to Evaluate Tolerability of a Modified Health-Dx
Status:
COMPLETED
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Single Blind, Randomized Control Study is designed to evaluate the tolerability of the Celero Systems' modified Health-Dx™ (mHDx) capsule.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
True
Is an Unapproved Device?:
True
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: